Page last updated: 2024-08-24
triptonide and Acute Myelogenous Leukemia
triptonide has been researched along with Acute Myelogenous Leukemia in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Li, M; Li, X; Shen, J; Wang, P; Wu, Z; Xu, R; Xu, Y | 1 |
Other Studies
1 other study(ies) available for triptonide and Acute Myelogenous Leukemia
Article | Year |
---|---|
Natural small molecule triptonide inhibits lethal acute myeloid leukemia with FLT3-ITD mutation by targeting Hedgehog/FLT3 signaling.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Female; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Nuclear Proteins; Proto-Oncogene Proteins c-myc; Signal Transduction; Tandem Repeat Sequences; Triterpenes; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays; Zinc Finger Protein Gli2 | 2021 |